|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | |
| A61P 3/04 |
| (11) | Number of the document | 2866825 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13737808.9 |
| Date of filing the European patent application | 2013-06-21 | |
| (97) | Date of publication of the European application | 2015-05-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/063004 |
| Date | 2013-06-21 |
| (87) | Number | WO 2014/005858 |
| Date | 2014-01-09 |
| (30) | Number | Date | Country code |
| 12174535 | 2012-07-01 | EP | |
| 201261694837 P | 2012-08-30 | US | |
| 12186781 | 2012-10-01 | EP | |
| 201261708162 P | 2012-10-01 | US |
| (72) |
JENSEN, Christine Bj rn, DK
RASMUSSEN, Mads Frederik, DK
ZDRAVKOVIC, Milan, DK
KRISTENSEN, Peter, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | USE OF LONG-ACTING GLP-1 PEPTIDES |
| USE OF LONG-ACTING GLP-1 PEPTIDES |